Skip to content

Clinical trials

Observational Carcinoma, Bronchogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Phase: Observational Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20151
20161
20172
20181
20191
20202
20212
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status5
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Blueprint Medicines Corporation1
Capital Medical University1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier de PAU1
Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s.1
RENAULT Patrick Aldo1
Technische Universität Dresden1
University Hospital, Brest1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic14
Lung Neoplasms8
Carcinoma, Non-Small-Cell Lung6
Bronchial Neoplasms5
Lung Diseases5
Neoplasms by Site4
Respiratory Tract Diseases4
Respiratory Tract Neoplasms4
Thoracic Neoplasms4
Neoplasms3

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.